| Name | Title | Contact Details |
|---|
Simply put, we`re transforming the aging experience so people live longer, healthier lives. By focusing on each person`s abilities and strengths–rather than their limitations–we believe we can impact the healthspan of older adults. Ignited by a passion to inspire older adults to live healthy, meaningful lives, we reach out with our ministries which include: independent and assisted living, rehabilitation, memory support and services including home care, adult day, home-delivered meals, hospice and transportation. As a nonprofit organization guided by Christian compassion, we were founded than 66 years ago as a place for aging Methodist ministers and their spouses to call home. Today, our services are delivered by 1,300 part- and full-time passionate team members throughout the state with a focus on creating healthier and longer lives.
RamSoft, Inc. is a Rancho Cucamonga, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Thank you for visiting our page. We want everyone to enjoy on our Wall so here are a few things that youll need to know in order to post. We reserve the right to delete a comment or post containing any of the following (NOTE: We may also block the ...
The Public Health Foundation of Columbia County is a Saint Helens, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.